Aztreonam

CAYSTON 75 mg POLVO Y DISOLVENTE PARA SOLUCION PARA INHALACION POR NEBULIZADOR

75 mg polvo para solución para inhalación por nebulizadorSpainMarketedAuthorised 26 May 2010

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Aztreonam

CAYSTON 75 mg POLVO Y DISOLVENTE PARA SOLUCION PARA INHALACION POR NEBULIZADOR

75 mg polvo para solución para inhalación por nebulizadorSpainMarketedAuthorised 26 May 2010

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Azeus

Brazil · Newcom Farmaceutica Ltda.

aztreonamBrazil · Instituto Biochimico Indústria Farmacêutica Ltda

AzactamNew Zealand · Inj 1 g vial

Aztreonam (Fresenius Kabi)New Zealand · Inj 1 g vial

AZACTAM FOR INJECTION 1 g/vialSingapore · 1 g/vial · injection, powder, for solution · Arrotex Pharmaceuticals Singapore Pte. LTD.

AztreonamUnited States · 1GM/VIAL, 2GM/VIAL, 500MG/VIAL · injectable · Hikma

AzactamUnited States · 1GM/VIAL, 2GM/VIAL, 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · injectable · Labs Delbert

Packs

Pack	Code	Status
CAYSTON 75 mg POLVO Y DISOLVENTE PARA SOLUCION PARA INHALACION POR NEBULIZADOR, 84 viales + 88 ampollas de disolvente	664248

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Aztreonam
Strength: 75 mg
Dosage form: polvo para solución para inhalación por nebulizador
Route: vía inhalatoria
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 26 May 2010
Registration: 09543002
Marketing authorisation holder: Gilead Sciences Ireland Unlimited Company
Procedure: EU centralised
Supply: Uso Hospitalario